This editorial discusses the progress and challenges in personalized therapy for non-small-cell lung cancer (NSCLC). It highlights the increasing complexity of NSCLC treatment due to the identification of numerous actionable oncogenic alterations, the development of targeted therapies, and the evolving understanding of resistance mechanisms. The editorial also addresses the need for improved molecular characterization techniques, the role of molecular tumor boards, the potential of liquid biopsy, and the applications of artificial intelligence in personalized medicine for NSCLC.
Publisher
International Journal of Molecular Sciences
Published On
May 04, 2023
Authors
Carlo Genova
Tags
personalized therapy
non-small-cell lung cancer
targeted therapies
molecular characterization
liquid biopsy
artificial intelligence
resistance mechanisms
Related Publications
Explore these studies to deepen your understanding of the subject.
